The Blue Ash firm ranked as the region’s 17th-largest private company last year with $1B in revenue. It's now being acquired in a $1.3B deal
A Greater Cincinnati company is the target of a $1.3 billion acquisition deal that would rank as the region’s largest since Meridian Bioscience sold to a pair of South Korean-based firms in early 2023.
A Greater Cincinnati company is the target of a $1.3 billion acquisition deal that would rank as the region’s largest since Meridian Bioscience sold to a pair of South Korean-based firms in early 2023.
